
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
LRRFIP1
Introduction
Leucine-rich repeat flightless-interacting protein 1 is a protein that in humans is encoded by the LRRFIP1 gene.[1][2][3][4]
References
References
- ↑ Reed AL, Yamazaki H, Kaufman JD, Rubinstein Y, Murphy B, Johnson AC (Sep 1998). “Molecular cloning and characterization of a transcription regulator with homology to GC-binding factor”. J Biol Chem. 273 (34): 21594–602. doi:10.1074/jbc.273.34.21594. PMID 9705290.
- ↑ 2.0 2.1 Liu YT, Yin HL (May 1998). “Identification of the binding partners for flightless I, A novel protein bridging the leucine-rich repeat and the gelsolin superfamilies”. J Biol Chem. 273 (14): 7920–7. doi:10.1074/jbc.273.14.7920. PMID 9525888.
- ↑ Suriano AR, Sanford AN, Kim N, Oh M, Kennedy S, Henderson MJ, Dietzmann K, Sullivan KE (Oct 2005). “GCF2/LRRFIP1 represses tumor necrosis factor alpha expression”. Mol Cell Biol. 25 (20): 9073–81. doi:10.1128/MCB.25.20.9073-9081.2005. PMC 1265793. PMID 16199883.
- ↑ “Entrez Gene: LRRFIP1 leucine rich repeat (in FLII) interacting protein 1”.
- ↑ Fong KS, de Couet HG (Jun 1999). “Novel proteins interacting with the leucine-rich repeat domain of human flightless-I identified by the yeast two-hybrid system”. Genomics. 58 (2): 146–57. doi:10.1006/geno.1999.5817. PMID 10366446.
Further reading
Further reading
- Wilson SA, Brown EC, Kingsman AJ, Kingsman SM (1998). “TRIP: a novel double stranded RNA binding protein which interacts with the leucine rich repeat of flightless I”. Nucleic Acids Res. 26 (15): 3460–7. doi:10.1093/nar/26.15.3460. PMC 147727. PMID 9671805.
- Khachigian LM, Santiago FS, Rafty LA, Chan OL, Delbridge GJ, Bobik A, Collins T, Johnson AC (1999). “GC factor 2 represses platelet-derived growth factor A-chain gene transcription and is itself induced by arterial injury”. Circ. Res. 84 (11): 1258–67. doi:10.1161/01.res.84.11.1258. PMID 10364563.
- Fong KS, de Couet HG (1999). “Novel proteins interacting with the leucine-rich repeat domain of human flightless-I identified by the yeast two-hybrid system”. Genomics. 58 (2): 146–57. doi:10.1006/geno.1999.5817. PMID 10366446.
- Rikiyama T, Curtis J, Oikawa M, Zimonjic DB, Popescu N, Murphy BA, Wilson MA, Johnson AC (2003). “GCF2: expression and molecular analysis of repression”. Biochim. Biophys. Acta. 1629 (1–3): 15–25. doi:10.1016/s0167-4781(03)00156-8. PMID 14522076.
- Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villén J, Li J, Cohn MA, Cantley LC, Gygi SP (2004). “Large-scale characterization of HeLa cell nuclear phosphoproteins”. Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. doi:10.1073/pnas.0404720101. PMC 514446. PMID 15302935.
- Beausoleil SA, Villén J, Gerber SA, Rush J, Gygi SP (2006). “A probability-based approach for high-throughput protein phosphorylation analysis and site localization”. Nat. Biotechnol. 24 (10): 1285–92. doi:10.1038/nbt1240. PMID 16964243.
- Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M (2006). “Global, in vivo, and site-specific phosphorylation dynamics in signaling networks”. Cell. 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID 17081983.
